Comabella, M.
~ 200  results:
Search for persons X
?
1

The genetic diversity of multiple sclerosis risk among Hisp..:

Beecham, AH ; Amezcua, L ; Chinea, A...
Multiple Sclerosis Journal.  26 (2019)  11 - p. 1329-1339 , 2019
 
?
3

Cognitive impairment in early stages of multiple sclerosis ..:

Quintana, E. ; Coll, C. ; Salavedra‐Pont, J....
European Journal of Neurology.  25 (2018)  9 - p. 1189-1191 , 2018
 
?
5

Response to interferon-beta treatment in multiple sclerosis..:

Mahurkar, S ; Moldovan, M ; Suppiah, V...
The Pharmacogenomics Journal.  17 (2016)  4 - p. 312-318 , 2016
 
?
6

Conversion from clinically isolated syndrome to multiple sc..:

Kuhle, J ; Disanto, G ; Dobson, R...
Multiple Sclerosis Journal.  21 (2015)  8 - p. 1013-1024 , 2015
 
?
7

Are Leber's mitochondial DNA mutations associated with aqua..:

Dujmovic, I ; Jancic, J ; Dobricic, V...
Multiple Sclerosis Journal.  22 (2015)  3 - p. 393-394 , 2015
 
?
8

Significant clinical worsening after natalizumab withdrawal..:

Vidal-Jordana, A ; Tintoré, M ; Tur, C...
Multiple Sclerosis Journal.  21 (2014)  6 - p. 780-785 , 2014
 
?
9

Cellular immune responses in multiple sclerosis patients tr..:

Bustamante, M F ; Rio, J ; Castro, Z...
Clinical and Experimental Immunology.  171 (2013)  3 - p. 243-246 , 2013
 
?
 
?
11

Treatment with interferon-beta does not induce anti-nuclear..:

Comabella, M. ; Rentzsch, K. ; Río, J....
Journal of Neuroimmunology.  255 (2013)  1-2 - p. 102-104 , 2013
 
?
12

TRPM4 mRNA expression levels in peripheral blood mononuclea..:

Malhotra, S. ; Castilló, J. ; Negrotto, L....
Journal of Neuroimmunology.  261 (2013)  1-2 - p. 146-148 , 2013
 
?
13

Early detection of neutralizing antibodies to interferon-be..:

Hegen, H ; Millonig, A ; Bertolotto, A...
Multiple Sclerosis Journal.  20 (2013)  5 - p. 577-587 , 2013
 
?
 
1-15